Dynavax names Pfizer veteran as board member
This article was originally published in Scrip
Berkeley, California-based, clinical-stage biopharmaceutical company Dynavax Technologies, has appointed Natale Ricciardi to its board of directors, effective from 8 July 2013. Mr Ricciardi previously spent 39 years working for Pfizer before retiring in 2011 – in his time at the firm he held several executive positions including president, Pfizer global manufacturing, and senior vice-president of the company. He currently sits on the board of the 21st Century Foundation of the City College of New York.